Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study
Yousef Zakharia(University of Iowa Hospitals and Clinics), Mohammed Milhem(University of Iowa Hospitals and Clinics)
Cited by 37
Related Papers
Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial
|Clinical Cancer Research|2023|26